{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:14Z","timestamp":1786979894555,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-023-03973-3","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T05:02:26Z","timestamp":1686200546000},"page":"2684-2694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Endometrial carcinoma: association between mutational status, sites of metastasis, recurrence, and correlation with overall survival"],"prefix":"10.1007","volume":"48","author":[{"given":"Cibele","family":"Luna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Wishnek","family":"Metalonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangnan","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1681-1284","authenticated-orcid":false,"given":"Francesco","family":"Alessandrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"issue":"10023","key":"3973_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer.\u00a0Lancet 2016;387(10023):1094-1108. doi:https:\/\/doi.org\/10.1016\/S0140-6736(15)00130-0","journal-title":"Lancet"},{"key":"3973_CR2","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021 [published correction appears in CA Cancer J Clin. 2021 Jul;71(4):359].\u00a0CA Cancer J Clin 2021;71(1):7-33. doi:https:\/\/doi.org\/10.3322\/caac.21654","DOI":"10.3322\/caac.21654"},{"key":"3973_CR3","unstructured":"US Surveillance, Epidemiology, and End Results (SEER). Cancer Stat Facts - Uterine Cancer: https:\/\/www.seer.cancer.gov\/statfacts\/html\/corp.html. Accessed January 5, 2022"},{"issue":"21","key":"3973_CR4","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMra1514010","volume":"383","author":"KH Lu","year":"2020","unstructured":"Lu KH, Broaddus RR. Endometrial Cancer.\u00a0N Engl J Med 2020;383(21):2053-2064. doi:https:\/\/doi.org\/10.1056\/NEJMra1514010","journal-title":"N Engl J Med"},{"key":"3973_CR5","doi-asserted-by":"publisher","unstructured":"Watanabe T, Nanamiya H, Kojima M, et al. Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma.\u00a0Transl Oncol 2021;14(3):101010. doi:https:\/\/doi.org\/10.1016\/j.tranon.2021.101010","DOI":"10.1016\/j.tranon.2021.101010"},{"issue":"4","key":"3973_CR6","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3892\/ol.2014.2362","volume":"8","author":"B Sorbe","year":"2014","unstructured":"Sorbe B, Juresta C, Ahlin C. Natural history of recurrences in endometrial carcinoma.\u00a0Oncol Lett 2014;8(4):1800-1806. doi:https:\/\/doi.org\/10.3892\/ol.2014.2362","journal-title":"Oncol Lett"},{"issue":"1","key":"3973_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/his.14015","volume":"76","author":"L Vermij","year":"2020","unstructured":"Vermij L, Smit V, Nout R, Bosse T. Incorporation of molecular characteristics into endometrial cancer management.\u00a0Histopathology 2020;76(1):52-63. doi:https:\/\/doi.org\/10.1111\/his.14015","journal-title":"Histopathology"},{"issue":"5","key":"3973_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/CCO.0000000000000560","volume":"31","author":"J Carlson","year":"2019","unstructured":"Carlson J, McCluggage WG. Reclassifying endometrial carcinomas with a combined morphological and molecular approach.\u00a0Curr Opin Oncol 2019;31(5):411-419. doi:https:\/\/doi.org\/10.1097\/CCO.0000000000000560","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"3973_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1525-1438.2007.00961.x","volume":"18","author":"H Fujiwara","year":"2008","unstructured":"Fujiwara H, Saga Y, Takahashi K, et al. Omental metastases in clinical stage I endometrioid adenocarcinoma.\u00a0Int J Gynecol Cancer 2008;18(1):165-167. doi:https:\/\/doi.org\/10.1111\/j.1525-1438.2007.00961.x","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"3973_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.crad.2006.06.015","volume":"62","author":"SA Sohaib","year":"2007","unstructured":"Sohaib SA, Houghton SL, Meroni R, Rockall AG, Blake P, Reznek RH. Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis.\u00a0Clin Radiol 2007;62(1):28-36. doi:https:\/\/doi.org\/10.1016\/j.crad.2006.06.015","journal-title":"Clin Radiol"},{"issue":"4","key":"3973_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3802\/jgo.2015.26.4.270","volume":"26","author":"ES Paik","year":"2015","unstructured":"Paik ES, Yoon A, Lee YY, et al. Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors.\u00a0J Gynecol Oncol 2015;26(4):270-276. doi:https:\/\/doi.org\/10.3802\/jgo.2015.26.4.270","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"3973_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3322\/caac.21561","volume":"69","author":"RA Brooks","year":"2019","unstructured":"Brooks RA, Fleming GF, Lastra RR, et al. Current recommendations and recent progress in endometrial cancer.\u00a0CA Cancer J Clin 2019;69(4):258-279. doi:https:\/\/doi.org\/10.3322\/caac.21561","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3973_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/IGC.0b013e31820575f5","volume":"21","author":"I Vandenput","year":"2011","unstructured":"Vandenput I, Trovik J, Leunen K, et al. Evolution in endometrial cancer: evidence from an immunohistochemical study.\u00a0Int J Gynecol Cancer 2011;21(2):316-322. doi:https:\/\/doi.org\/10.1097\/IGC.0b013e31820575f5","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"3973_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41568-019-0177-x","volume":"19","author":"ME Urick","year":"2019","unstructured":"Urick ME, Bell DW. Clinical actionability of molecular targets in endometrial cancer.\u00a0Nat Rev Cancer 2019;19(9):510-521. doi:https:\/\/doi.org\/10.1038\/s41568-019-0177-x","journal-title":"Nat Rev Cancer"},{"key":"3973_CR15","doi-asserted-by":"publisher","unstructured":"Alessandrino F, Goncalves N, Wishnek Metalonis S, Luna C, Mason MM, Lyu J, Huang M.\u00a0Uterine serous carcinoma: assessing association between genomics and patterns of metastasis. Frontiers in Oncology.\u00a0DOI: https:\/\/doi.org\/10.3389\/fonc.2022.1066427 (accepted for publication).","DOI":"10.3389\/fonc.2022.1066427"},{"issue":"S1","key":"3973_CR16","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1016\/S0090-8258(22)01431-7","volume":"166","author":"F Alessandrino","year":"2022","unstructured":"Alessandrino F, Goncalves N, Luna C, Mason M, Castillo P, Huang M. Endometrial serous carcinoma: Association between race and ethnicity, mutational status, sites of metastasis and recurrence, and correlation with overall survival (205). Abstract. Gynecologic Oncology 2022. 166\/S1: S115-S116. doi:org\/https:\/\/doi.org\/10.1016\/S0090-8258(22)01431-7.","journal-title":"Abstract. Gynecologic Oncology"},{"key":"3973_CR17","doi-asserted-by":"publisher","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumors: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45(2):228\u2013247. doi:https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"3973_CR18","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research Network, Kandoth C, Schultz N, et al. Integrated genomic characterization of endometrial carcinoma [published correction appears in Nature. 2013 Aug 8;500(7461):242].\u00a0Nature 2013;497(7447):67-73. doi:https:\/\/doi.org\/10.1038\/nature12113","DOI":"10.1038\/nature12113"},{"key":"3973_CR19","doi-asserted-by":"publisher","unstructured":"Colomer R, Mondejar R, Romero-Laorden N, Alfranca A, Sanchez-Madrid F, Quintela-Fandino M. When should we order a next generation sequencing test in a patient with cancer?.\u00a0EClinicalMedicine 2020;25:100487. doi:https:\/\/doi.org\/10.1016\/j.eclinm.2020.100487","DOI":"10.1016\/j.eclinm.2020.100487"},{"issue":"4","key":"3973_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/jmcb\/mjy072","volume":"11","author":"X Zhou","year":"2019","unstructured":"Zhou X, Hao Q, Lu H. Mutant p53 in cancer therapy-the barrier or the path.\u00a0J Mol Cell Biol 2019;11(4):293-305. doi:https:\/\/doi.org\/10.1093\/jmcb\/mjy072","journal-title":"J Mol Cell Biol"},{"issue":"20 Pt 1","key":"3973_CR21","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1158\/1078-0432.CCR-06-1375","volume":"12","author":"MP Hayes","year":"2006","unstructured":"Hayes MP, Wang H, Espinal-Witter R, et al. PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia.\u00a0Clin Cancer Res 2006;12(20 Pt 1):5932-5935. doi:https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-1375","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3973_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ygyno.2017.11.027","volume":"148","author":"D Smith","year":"2018","unstructured":"Smith D, Stewart CJR, Clarke EM, et al. ER and PR expression and survival after endometrial cancer.\u00a0Gynecol Oncol 2018;148(2):258-266. doi:https:\/\/doi.org\/10.1016\/j.ygyno.2017.11.027","journal-title":"Gynecol Oncol"},{"issue":"14","key":"3973_CR23","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1002\/cncr.28017","volume":"119","author":"DM Roque","year":"2013","unstructured":"Roque DM, Bellone S, English DP, et al. Tubulin-\u03b2-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum\/taxane chemotherapy and sensitivity to epothilones.\u00a0Cancer 2013;119(14):2582-2592. doi:https:\/\/doi.org\/10.1002\/cncr.28017","journal-title":"Cancer"},{"issue":"6","key":"3973_CR24","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/IGC.0b013e318218f28b","volume":"21","author":"I Vandenput","year":"2011","unstructured":"Vandenput I, Capoen A, Coenegrachts L, et al. Expression of ERCC1, p53, and class III \u03b2-tubulin do not reveal chemoresistance in endometrial cancer: results from an immunohistochemical study.\u00a0Int J Gynecol Cancer 2011;21(6):1071-1077. doi:https:\/\/doi.org\/10.1097\/IGC.0b013e318218f28b","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"3973_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ygyno.2017.07.145","volume":"149","author":"CM Tarney","year":"2018","unstructured":"Tarney CM, Tian C, Wang G, et al. Impact of age at diagnosis on racial disparities in endometrial cancer patients.\u00a0Gynecol Oncol 2018;149(1):12-21. doi:https:\/\/doi.org\/10.1016\/j.ygyno.2017.07.145","journal-title":"Gynecol Oncol"},{"issue":"20","key":"3973_CR26","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1002\/cncr.30813","volume":"123","author":"NW Bateman","year":"2017","unstructured":"Bateman NW, Dubil EA, Wang G, et al. Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.\u00a0Cancer 2017;123(20):4004-4012. doi:https:\/\/doi.org\/10.1002\/cncr.30813","journal-title":"Cancer"},{"issue":"8","key":"3973_CR27","first-page":"2999","volume":"6","author":"GL Maxwell","year":"2000","unstructured":"Maxwell GL, Risinger JI, Hayes KA, et al. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers.\u00a0Clin Cancer Res 2000;6(8):2999-3005.","journal-title":"Clin Cancer Res"},{"issue":"16","key":"3973_CR28","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","volume":"22","author":"E Stelloo","year":"2016","unstructured":"Stelloo E, Nout RA, Osse EM, et al. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.\u00a0Clin Cancer Res 2016;22(16):4215-4224. doi:https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2878","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3973_CR29","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/cncr.30496","volume":"123","author":"A Talhouk","year":"2017","unstructured":"Talhouk A, McConechy MK, Leung S, et al. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.\u00a0Cancer 2017;123(5):802-813. doi:https:\/\/doi.org\/10.1002\/cncr.30496","journal-title":"Cancer"},{"issue":"3","key":"3973_CR30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1148\/radiol.2020191770","volume":"295","author":"F Alessandrino","year":"2020","unstructured":"Alessandrino F, Williams K, Nassar AH, et al. Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival.\u00a0Radiology 2020;295(3):572-580. doi:https:\/\/doi.org\/10.1148\/radiol.2020191770","journal-title":"Radiology"},{"issue":"9","key":"3973_CR31","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1002\/cam4.1742","volume":"7","author":"M Baskovic","year":"2018","unstructured":"Baskovic M, Lichtensztajn DY, Nguyen T, Karam A, English DP. Racial disparities in outcomes for high-grade uterine cancer: A California cancer registry study.\u00a0Cancer Med 2018;7(9):4485-4495. doi:https:\/\/doi.org\/10.1002\/cam4.1742","journal-title":"Cancer Med"},{"issue":"4","key":"3973_CR32","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/cncr.32598","volume":"126","author":"OD Lara","year":"2020","unstructured":"Lara OD, Wang Y, Asare A, et al. Pan-cancer clinical and molecular analysis of racial disparities.\u00a0Cancer 2020;126(4):800-807. doi:https:\/\/doi.org\/10.1002\/cncr.32598","journal-title":"Cancer"},{"issue":"16","key":"3973_CR33","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1016\/j.ejca.2013.06.016","volume":"49","author":"J Trovik","year":"2013","unstructured":"Trovik J, Wik E, Werner HM, et al. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.\u00a0Eur J Cancer 2013;49(16):3431-3441. doi:https:\/\/doi.org\/10.1016\/j.ejca.2013.06.016","journal-title":"Eur J Cancer"},{"key":"3973_CR34","doi-asserted-by":"publisher","first-page":"8879","DOI":"10.2147\/CMAR.S338861","volume":"13","author":"Z Yu","year":"2021","unstructured":"Yu Z, Wei S, Zhang J, et al. Development and Validation of a Novel Prognostic Model for Endometrial Cancer Based on Clinical Characteristics.\u00a0Cancer Manag Res 2021;13:8879-8886. doi:https:\/\/doi.org\/10.2147\/CMAR.S338861","journal-title":"Cancer Manag Res"},{"key":"3973_CR35","doi-asserted-by":"publisher","unstructured":"Fan Y, Li X, Tian L, Wang J. Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients.\u00a0Front Oncol 2021;11:630905. doi:https:\/\/doi.org\/10.3389\/fonc.2021.630905","DOI":"10.3389\/fonc.2021.630905"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-03973-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-023-03973-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-03973-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T05:08:54Z","timestamp":1688965734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-023-03973-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["3973"],"URL":"https:\/\/doi.org\/10.1007\/s00261-023-03973-3","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"24 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval was obtained from the University of Miami Human Research Ethics committee (ethics approval number: 20080362).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all subjects to store samples and data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}